Additionally, in the last decade PHOX2B has moved to the main genetic landscape of neuroblastoma [69,72], becoming a reliable diagnostic marker in tissue and cytology specimens [12,73], and a specific and sensitive biomarker for minimal residual disease in neuroblastoma [74]. This evidence concerns the gene PHOX2B and neuroblastoma.